The novel brain penetrant ataxia-telangiectasia mutated inhibitor WSD0628 provides robust radiosensitization of brain tumor patient-derived xenografts. [PDF]
Xue Z +21 more
europepmc +1 more source
Pioglitazone as a Possible Treatment for <i>Ataxia-Telangiectasia</i>. [PDF]
Shackelford R.
europepmc +1 more source
Prevalence and outcomes of cancer and treatment-associated toxicities for patients with ataxia telangiectasia. [PDF]
Magnarelli A +13 more
europepmc +1 more source
Ataxia-telangiectasia and malignancies.
A I Berkel, F Ersoy
openaire +2 more sources
Ataxia telangiectasia in a Bahraini child treated with intensive physiotherapy: A case report. [PDF]
Razzaqi F, Albastaki A, Sinan I.
europepmc +1 more source
Is high AFP associated with liver diseases in ataxia-telangiectasia and ataxia-oculomotor apraxia? [PDF]
Ismayilov R +7 more
europepmc +1 more source
Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938). [PDF]
Villaruz LC +35 more
europepmc +1 more source
Novel pathogenic ATM mutation with ataxia-telangiectasia in a Chinese family. [PDF]
Zhou Q, Chen M, Tao E.
europepmc +1 more source
Targeting Ataxia Telangiectasia-Mutated and Rad3-Related for Anaplastic Thyroid Cancer. [PDF]
Lin SF +4 more
europepmc +1 more source
ATM Expression and Activation in Ataxia Telangiectasia Patients with and without Class Switch Recombination Defects. [PDF]
Salami F +18 more
europepmc +1 more source

